J Clin Immunol. 2026 Mar 26. doi: 10.1007/s10875-026-02011-3. Online ahead of print. NO ABSTRACT PMID:41882201 | DOI:10.1007/s10875-026-02011-3
J Clin Immunol. 2026 Mar 24. doi: 10.1007/s10875-026-02006-0. Online ahead of print. NO ABSTRACT PMID:41874828 | DOI:10.1007/s10875-026-02006-0
J Clin Immunol. 2026 Mar 23. doi: 10.1007/s10875-026-02013-1. Online ahead of print. NO ABSTRACT PMID:41870648 | DOI:10.1007/s10875-026-02013-1
J Clin Immunol. 2026 Mar 21. doi: 10.1007/s10875-026-02001-5. Online ahead of print. NO ABSTRACT PMID:41863686 | DOI:10.1007/s10875-026-02001-5
J Clin Immunol. 2026 Mar 21. doi: 10.1007/s10875-026-02005-1. Online ahead of print. NO ABSTRACT PMID:41863683 | DOI:10.1007/s10875-026-02005-1
J Clin Immunol. 2026 Mar 21. doi: 10.1007/s10875-026-02004-2. Online ahead of print. NO ABSTRACT PMID:41863562 | DOI:10.1007/s10875-026-02004-2
J Clin Immunol. 2026 Mar 14. doi: 10.1007/s10875-026-01995-2. Online ahead of print. ABSTRACT TREC-NBS identifies patients with inborn errors of immunity (IEI) and syndromic features, but uncertainty remains regarding their immunological management. To address this, syndromic patients detected by TREC-NBS in Germany between August 2019 and April 2024 were systematically analyzed, including phenotype, treatment, and … Read more
J Clin Immunol. 2026 Mar 7. doi: 10.1007/s10875-026-02002-4. Online ahead of print. NO ABSTRACT PMID:41793545 | DOI:10.1007/s10875-026-02002-4
J Clin Immunol. 2026 Mar 7. doi: 10.1007/s10875-026-02000-6. Online ahead of print. NO ABSTRACT PMID:41795040 | DOI:10.1007/s10875-026-02000-6
J Clin Immunol. 2026 Mar 6. doi: 10.1007/s10875-026-01989-0. Online ahead of print. NO ABSTRACT PMID:41790376 | DOI:10.1007/s10875-026-01989-0
